Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)

Market Cap	4.01B +22.4%
Revenue (ttm)	843.87M -20.6%
Net Income	49.37M +129.2%
EPS	0.16 +129.1%
Shares Out	303.35M
PE Ratio	81.15
Forward PE	n/a
Dividend	0.04 (0.28%)
Ex-Dividend Date	May 22, 2026

Volume	71,213,950
Open	14.82
Previous Close	13.21
Day's Range	13.24 - 15.24
52-Week Range	6.78 - 15.62
Beta	0.45
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About SHE:300534

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health products in China and internationally. It is also involved in the cultivation, processing, and sales of chemical drugs and medicinal herbs, as well as pharmaceutical distribution, testing, and inspection services. The company was founded in 2002 and is based in Lanzhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2002
• Employees: 641
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300534

Financial Performance

In 2025, SHE:300534's revenue was 886.96 million, a decrease of -14.92% compared to the previous year's 1.04 billion. Earnings were 43.95 million, an increase of 79.56%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 30, 2026

Data Sources Report a data error